Search

everythinglearnresearchcommunity

for

Search:↓

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Post-COVID syndrome symptoms are common and overlap with general health issues.

Cochrane systematic reviews have better methodological quality than non-Cochrane ones, and improvements are needed for the latter.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

Individualized treatment improves symptoms and quality of life for women with PCOS.

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.

Women with PCOS have higher levels of certain androgens, which are good at predicting excess hair growth.

Early detection and treatment of urinary symptoms can help maintain functional ability in older adults.

Breast cancer patients need better psychological support to improve their quality of life.

Women with PCOS may have a reduced ability to fight breast tumor cells over time.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Anovulatory PCOS patients are younger with longer cycles and higher blood pressure and hormone levels.

Presurgical models can effectively and affordably screen cancer prevention agents.

Many late adolescent girls lack knowledge and have negative attitudes about PCOS.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Women with PCOS have altered brain structure and reduced cognitive performance.

11-oxyandrogens are linked to excess hair growth in PCOS, but don't help diagnose it.

Thorough evaluation is crucial for postmenopausal women with virilization to detect rare ovarian tumors.

The submission argued that CPSO's referral policy undermines doctors' civil liberties and recommended changes to protect conscientious objections.

The CTLA-4 gene change studied does not affect Polycystic Ovarian Syndrome in the women tested.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Some medications can reduce excessive hair growth in women, but more research is needed to find the best treatment combinations.

Fetuin-A levels are higher in PCOS patients, suggesting it may play a role in the condition.

Women with PCOS are much more likely to have sleep problems and should be checked for them.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.